Abivax ABVX
NASDAQ ABVX
$92.61 -0.88 (-0.94%)
As of: Oct 22, 2026 · 10:39 AM EDT

Abivax (ABVX) EBT Margin (2024 - 2026)

Updated

Analysis

Abivax (ABVX) EBT Margin (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,163.39 Bn 1,131.97 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 634.39 Bn 552.91 Bn 17.26 Bn 26.66%
3 AbbVie 502.68 Bn 475.79 Bn 12.70 Bn 25.18%
4 Merck 377.37 Bn 331.74 Bn 12.21 Bn -4.11%
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn 29.63%
6 Astrazeneca 266.55 Bn 240.24 Bn 12.86 Bn 18.19%
7 Amgen 240.56 Bn 195.96 Bn 7.24 Bn 27.53%
8 Gilead Sciences 193.19 Bn 167.38 Bn 6.22 Bn -131.41%
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -4.34%
10 Abivax 6.41 Bn 4.06 Bn - -272.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -272.40%
Sep 30, 2025 -159.07%
Jun 30, 2025 -867.95%
Mar 31, 2025 -2,430.16%
Dec 31, 2024 -4,541.87%
Sep 30, 2024 -528.13%
Jun 30, 2024 -415.41%
Mar 31, 2024 -633.94%
API Access

Abivax EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEY